MONDAY, June 3, 2024 (HealthDay News) — Ozempic and Wegovy appear to improve people’s sensitivity to tastes, potentially lowering their desire for sweets, a new study suggests. The active ingredient in the weight-loss medications, semaglutide, also appears to affect the way that the tongue and brain respond to sweet tastes,Continue Reading
MONDAY, June 3, 2024 (HealthDay News) — Ozempic and Wegovy might help lower the risk of pancreatitis in patients with obesity and type 2 diabetes, a new study says. Up to now, doctors have been cautious about prescribing semaglutide to patients with a history of pancreatitis, because they feared theContinue Reading
FRIDAY, May 24, 2024 (HealthDay News) — Ozempic provides a wide variety of health benefits for people with kidney disease and type 2 diabetes, a major clinical trial has found. The drug significantly reduces the risk of severe kidney events, heart problems and death from any cause in patients whoContinue Reading
THURSDAY, May 23, 2024 (HealthDay News) — Three months after starting one of the new GLP-1 weight-loss drugs, more than a quarter of patients have already quit the medications, and by a year from first use more than a third have stopped, new research shows. Reasons for quitting Wegovy, OzempicContinue Reading
WEDNESDAY, May 22, 2024 (HealthDay News) — The number of American teens and young adults who’ve been prescribed one of the new GLP-1 weight-loss drugs soared nearly seven-fold between 2020 and 2023, a new report finds. That’s compared to an overall decline of about 3% in young Americans’ use ofContinue Reading
TUESDAY, May 21, 2024 (HealthDay News) — You’ve watched others shed pounds in a matter of weeks after taking one of the new blockbuster weight-loss drugs, so you decide to try one of the medications yourself, only to discover the needle on your bathroom scale barely budges. Why? New researchContinue Reading
MONDAY, May 20, 2024 (HealthDay News) — New, real-world research confirms that the blockbuster weight-loss drugs that millions of Americans have been taking to shed pounds can trigger stomach paralysis in some patients. “Although these drugs do work and should be used for the right reason, we just want toContinue Reading
FRIDAY, May 17, 2024 (HealthDay News) — The smell of food is appetizing when you’re hungry. At the same time, it can be a turnoff if you’re full. That’s due to the interaction between two different parts of the brain involving sense of smell and behavior motivation, a new studyContinue Reading
WEDNESDAY, May 15, 2024 (HealthDay News) — A competitive game with a potential cash reward appeared to help overweight British men lose weight, researchers report. The incentive was winning the “Game of Stones” — a stone is a British measurement of body weight equal to 14 pounds — and pocketingContinue Reading
TUESDAY, May 14, 2024 (HealthDay News) — Semaglutide — the active ingredient in the blockbuster weight-loss drugs Ozempic and Wegovy — can produce long-term weight and heart health benefits, a pair of new studies show. Researchers found that overweight and obese adults lost an average 10% of their body weightContinue Reading
TUESDAY, May 14, 2024 (HealthDay News) — Women who smoke during pregnancy run a higher risk of their kids becoming overweight or obese, and researchers now think they know one reason why. Children born of moms who smoked while expecting tend to have gut bacteria that is significantly different fromContinue Reading
MONDAY, May 13, 2024 (HealthDay News) — People with heart failure are often prescribed what are known as loop diuretic medications to help reduce the fluid buildup that’s a hallmark of the disease. Now, research suggests that taking the blockbuster weight loss drug Wegovy (semaglutide) can help patients reduce theirContinue Reading
MONDAY, May 13, 2024 (HealthDay News) — “Skinny” fat cells might actually make it harder to lose weight and easier to pack on extra pounds, a new study says. Researchers say it’s possible to predict if someone’s going to gain weight based solely on the size of their fat cells.Continue Reading
FRIDAY, May 10, 2024 (HealthDay News) — About 1 in 8 U.S. adults (12%) have tried a weight-loss drug like Wegovy, Ozempic, Zepbound or Mounjaro, a new KFF Health Tracking Poll says. About 6% are taking one right now, the poll found. Most patients say they use the drugs (61%)Continue Reading